[2025] QCAT 510
General information, not legal advice.
Queensland Civil and Administrative Tribunal
2025-12-11
Professor P, Dr J
Original judgment source is linked above.
(a) Whether allegation eight should include findings beyond Person A;
(b) Depending on the answer to (a), whether the Tribunal should make a separate finding that the respondent's admitted conduct is professional misconduct or unprofessional conduct;
(c) Whether the respondent's admitted conduct in respect of each of allegations seven and nine supports findings of unprofessional conduct;
(d) Whether the appropriate final order is a reprimand, as proposed by the Board or no further sanction as proposed by the respondent.
(a) He prescribed medications to Person A between 11 August 2019 and about 3 July 2020[3]. That involved a total of 86 prescriptions[4] and included prescribing paracetamol + codeine on 51 occasions and tramadol on 17 occasions[5];
(b) Apart from the first occasion on which he prescribed paracetamol + codeine and tramadol, he did not undertake an adequate clinical assessment of Person A prior to giving each of those prescriptions;
(c) He failed to make any clinical record of any assessment undertaken with respect to the other medications he prescribed to Person A;
(d) He did not provide appropriate follow up care to Person A in respect of her ongoing use of, and need for, paracetamol + codeine and tramadol and he prescribed those drugs in (cumulatively) large quantities that were not appropriate in the circumstances;
(e) On about 14 October 2019 he treated Person A when she presented at the hospital where they both worked, by administering 5ml of a solution of Betamethasone 6mg in 20ml;
(f) This conduct constitutes professional misconduct.
(a) Person A and the respondent met in about June 2019 at the hospital where both of them worked. Person A was employed as an acute care clinician;
(b) In or around June 2019 Person A and the respondent developed an intimate and personal relationship;
(c) In about August 2019 Person A and the respondent met outside work in a social context and she asked that he prescribe her pain relief for her rib;
(d) On about 11 August 2019 the respondent prescribed Panadeine Forte at a quantity of 20 tablets with no repeats for Patient A;
(e) On about 14 October 2019 the respondent treated Person A at the hospital where they both worked, by administering 5ml of a solution of Betamethasone 6mg in 20ml 1%) and he administered a second injection five to seven days later at her house;
(f) From about November 2019 Person A and the respondent cohabited on and off, then, from January 2020 they cohabited on a consistent basis;
(g) In early July 2020 Person A and the respondent moved towns as a family unit;
(h) Their relationship ended late 2020;
(i) The respondent failed to maintain appropriate professional boundaries with Person A to the extent that he regularly provided Person A with medications whilst in an intimate and personal relationship with her;
(j) This conduct constitutes professional misconduct.
(a) he made out prescriptions for Person A using prescription pads from two hospitals and for each of Persons B, C, D and E he used a prescription pad from a hospital when none of the patients were patients of the hospital;
(b) in the period from 13 June 2019 to 3 July 2020 as reflected by the actions in sub-paragraph (a), the respondent failed to use and store prescription pads in accordance with proper practice.
How should the Tribunal characterise the practitioner's conduct ?
(a) The treatment of eczema is unavoidable or cannot be delayed; and/or
(b) A request could have been made for Person D's usual medical practitioner to issue a repeat prescription for Cortival cream pending an appointment; and/or
(c) Other treatments for eczema are available over the counter at a pharmacy such that the circumstances of Person D suffering from eczema do not justify prescribing for someone the Respondent was in a close relationship with.
What does the Tribunal conclude on the characterisation question ?
(a) preventing practitioners who are unfit to practice from practicing;
(b) bringing home to the practitioner the seriousness of their conduct;
(c) deterring the practitioner from future departure from appropriate standards or others who might be minded to act in a similar way; and
(d) imposing restrictions on the practitioner's right to practice to ensure public protection.
(a) The respondent's admissions which have enabled this matter to proceed efficiently;
(b) The period of time during which the respondent's registration was suspended, which was a period of nearly two years;
(c) The absence of any further notifications relating to the respondent's personal conduct or his performance of the profession, since these allegations, which relate to conduct now five years ago;
(d) The respondent's ongoing compliance with the Health Conditions the Board imposed in December 2020;
(e) The respondent's current stable employment since July 2024;
(f) The education completed by the respondent in response to the notification; and
(g) The character reference of his current supervisor, provided by way of affidavit.
"...Tsiaris, Verdins and Goodger and many other decisions recognise that a sentence which involves imprisonment actually to be served may often weigh more heavily on an offender suffering from psychiatric ill health just as an offender who suffers from physical deficits will experience more difficulty in prison than a person of normal robust health. It is usual for a sentencing court to moderate a sentence to balance this factor ..." and further at [33] "... that a prisoner suffering from serious psychiatric illness is not an appropriate vehicle for general deterrence..."
(a) In August 2020, when he saw the respondent, the respondent had reasonable insight into his condition and the respondent's judgment was socially competent. At that time the respondent presented as feeling somewhat overwhelmed, with lowering of mood, problematic sleep and lessening in his energy and concentration levels;
(b) The respondent is aware of the adverse impact of work stress and other stressors in destabilising his mood;
(c) The respondent recognises the benefits of mood stabilisers;
(d) The respondent would benefit from regular psychological therapies in managing his Bipolar Disorder Type II as well as continuing on mood stabilisers; and
(e) The respondent is to be wary of increased work demands.
[1] Board's submissions Hearing Brief (HB) 296 [11]; respondent's submissions HB 337 [11].
[2] The respondent had some time off on sick leave and completed a return to work plan on 30 March 2021 HB 249 [48].
[3] Agreed schedule of prescriptions HB 235-238.
[4] Board's submissions HB 310 [150](g)
[5] Totalling 1,040 tablets of paracetamol + codeine over 330 days between 12 August 2019 and 7 July 2020; 340 tablets of tramadol over 219 days between 8 September 2019 and 14 April 2020: Board's submissions HB 310 [151].
[7] Respondent's affidavit HB 143 [91].
[9] Health Ombudsman v Niem Quoc Tang [2020] QCAT 165 [17].
[10] Board's submissions HB 313 [175].
[11] Board's submissions HB 314 [183] - [184].
[12] Nursing and Midwifery Board of Australia v LYS [2024] QCAT 209 [87].
[13] Health Ombudsman v JTM [2020] QCAT 394 [21].
[14] Respondent's affidavit HB 133 [19] - [20].
[16] Respondent's submissions HB 133 [19].
[18] Craig v South Australia [2001] SASC 169; (2001) 79 SASR 545, 553- 555.
[19] Nursing and Midwifery Board of Australia v Lockie [2022] QCAT 391 (Lockie) [71] citing Medical Board of Australia v Bromeley [2018] QCAT 163 [142].
[20] Nursing and Midwifery Board of Australia v Lockie [2023] QCA 96 [45].
[21] Health Care Complaints Commission v Litchfield [1997] NSWSC 297; (1997) 41 NSWLR 630 [638].
[23] Respondent's submissions at [27].
[25] [2025] QCAT 240 [23].
[26] [2011] QCA 367 [32].
[27] Psychology Board of Australia v Cameron [2015] QCAT 227 [25].
Medical Board of Australia
ZQX
(2001) 79 SASR 545
(1997) 41 NSWLR 630